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A survey to determine usual care after
cancer treatment within the United
Kingdom national health service
M. Duncan1, J. Deane2, P. D. White1, D. Ridge3, R. Roylance4, A. Korszun1, T. Chalder5, K. S. Bhui1, M. A. Thaha6,
L. Bourke7* and on behalf of the SURECAN investigators
Abstract
Background: Approximately one third of cancer survivors in the United Kingdom face ongoing and debilitating
psychological and physical symptoms related to poor quality of life. Very little is known about current post-cancer
treatment services.
Methods: Oncology healthcare professionals (HCPs) were invited to take part in a survey, which gathered both
quantitative and free text data about the content and delivery of cancer aftercare and patient needs. Analysis
involved descriptive statistics and content analysis.
Results: There were 163 complete responses from 278 survey participants; 70% of NHS acute trusts provided data.
HCPs views on patient post-cancer treatment needs were most frequently: fear of recurrence (95%), fatigue (94%),
changes in physical capabilities (89%), anxiety (89%) and depression (88%). A median number of 2 aftercare sessions
were provided (interquartile range: 1,4) lasting between 30 and 60 min. Usually these were provided face-to-face
and intermittently by a HCP. However, sessions did not necessarily address the issues HCPs asserted as important.
Themes from free-text responses highlighted inconsistencies in care, uncertain funding for services and omission
of some evidence based approaches.
Conclusion: Provision of post-cancer treatment follow-up care is neither universal nor consistent in the NHS, nor
does it address needs HCPs identified as most important.
Keywords: Cancer, Survey, Quality of Life, NHS, Post-treatment, Follow-up
Background
Two million people now live with or beyond cancer in
the UK [1]. Although many cancer survivors report good
health, a substantial proportion of between 10 and 20%
(those without a chronic condition), may have ongoing
poor health and serious disability. For those with an add-
itional chronic condition this may be as high as 25–30%
[2]. A national survey (n = 3300) assessing the quality of
life (QoL) of adult cancer survivors reported that issues
affecting cancer survivors included: fear of recurrence
(57%), fatigue (43%), body image concerns (31%)
complete lack of exercise (30%) and sexual problems
(27%) [3]. Prospective cohort data revealed similar find-
ings with 30% of UK cancers survivors reporting more
than five unmet needs or problems, including fear of re-
currence, fatigue, anxiety, depression, limited independ-
ent living and not knowing how to “get better” - the
majority of these issues remained unresolved [4]. Conse-
quently, we surmise around a third of NHS cancer survi-
vors have poor QoL related to multiple ongoing and
unaddressed problems. Such issues are of course not
unique to the UK: both in Europe [5] and the US [6–8]
cancer survivorship initiatives and addressing unmet
post-treatment needs is being increasingly recognised as
an important part of cancer care.
Given the move to patient directed self-management
following active cancer treatment, it is essential that
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individuals with ongoing poor health and related prob-
lems are identified and offered appropriate support. No
recent studies in the UK have assessed how or the extent
to which ongoing unmet needs are identified and what
measures are taken to improve or recover post-treatment
QoL for cancer survivors within the NHS. Hence, it is cur-
rently unclear whether there is a cohesive or system-wide
approach to these issues. This is despite an existing evi-
dence base for interventions that can address some of
the problems faced by people during and after cancer
treatment. For example, psychosocial interventions
have been shown to have beneficial effects on depres-
sion, anxiety and stress [9, 10]. Cognitive behavioural
therapy (CBT) has been shown to benefit and sustain
QoL improvements in cancer survivors [11, 12]. Similarly,
exercise interventions have received support for benefiting
QoL in several meta-analyses [13–15]. Where appropriate,
vocational rehabilitation and helping people return to
work are also of critical importance from an individual
and economic perspective [16, 17]. Therefore, the aim
of this survey was to assess service provision for pa-
tients completing curative treatment for cancer in UK
NHS practice, together with the views of health care
professionals (HCPs) about areas for improvement in
the current service provision.
Methods
Measures
A 22 item standardised survey, including Likert scoring
and free text questions, was designed to determine
what is provided as part of usual care within the NHS
for patients who have finished active cancer treatment
with curative intent, it also asked what particular prob-
lems were thought to be related to poor QoL (see
online Additional file 1). The survey was ’standardised’
in that the same questions were presented in the same
format, sequence and via the same delivery method (i.e.
online) to all participants. The survey was developed
through feedback after piloting it with cancer HCPs
and patients. All questions required an answer. The
survey was sent to a range of professional bodies to try
to capture all relevant HCPs involved in the manage-
ment of cancer patients working in a range of clinical
settings. These included the Association of Cancer
Physicians, the UK Oncology Nurses Society, the Royal
College of Radiologists, the UK Breast Intergroup,
British Psychological Society and the Association of
Coloproctology of Great Britain and Ireland. The pro-
fessional bodies distributed the survey to their mem-
bers via email link that was open from August to
December 2015. The survey was sent to HCPs only.
The approval for the survey as a service evaluation was
gained via Barts Health NHS trust (Reg No. 6131).
Respondent characteristics
Participants were asked their country of practice (within
the UK), profession, cancer speciality, institute type and
number of years of practice in cancer care.
Service provision
Participants were asked how many people living with
and beyond cancer attend their service yearly, whether a
specific assessment was employed, an intervention or
therapy provided, and which professionals were involved
in this provision. A five point Likert scale (never to always)
was used to ask respondents whether specific interven-
tions were offered, and what aspects of living beyond can-
cer were addressed in their service. Five more questions
asked respondents about the format, number, frequency
and duration of the interventions offered and how the ses-
sions were delivered (e.g. face-to-face, telephone etc).
Professional opinion
Participants were asked to rate what were the most
important needs of people living with and beyond cancer
on a 5 point Likert scale (unimportant to very important).
A free text box was also provided to allow participants
to describe what more could be done to support people
living with and beyond cancer.
Procedure
The survey questions were initially piloted with oncology
consultants experienced in the management of a range
of malignancies to ensure that the content, language and
length of the survey were appropriate. Patient feedback
was also incorporated. Following participant feedback,
survey questions were refined before being sent out to
study participants. The aforementioned professional
bodies and groups were contacted and agreed to distribute
the final survey to their members via a link in an email.
The participants completed the survey through the online
tool SurveyMonkey (https://www.surveymonkey.com/). It
was made clear to participants that the survey referred to
the care of people who have completed their cancer treat-
ment delivered with curative intent.
Data analysis
The results of the survey were summarised using de-
scriptive statistics (e.g. percentages, means and standard
deviations, as appropriate). To aid data interpretation,
some responses were converted into categorical scores,
for example, the four answer options ‘never’, ‘rarely’, ‘fre-
quently’ and ‘always’ were merged into two categories by
collapsing ‘never’ and ‘rarely’ and ‘frequently’ and
‘always’. The free text responses were analysed using the-
matic analysis [18]. Emerging themes were identified by
MD using the Nvivo software to aid the coding and or-
ganisation of the free text responses. The initial analysis
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involved continually moving between reviewing the re-
sponses, coding, linking codes, and revising and reshaping
the analysis. MD then wrote up thematic topic summaries,
which were reviewed by LB and DR.
Results
Participants
There was a total of 278 responses, of which 163 had
completed through to the end of the survey, resulting in
a 59% full completion rate. 108 of the 154 (70%) acute
NHS trusts were represented in the survey (i.e. at least
one response from an individual within a NHS acute
trust). We received responses from the Association of
Cancer Physicians, the UK Oncology Nurses Society, the
Royal College of Radiologists, and the UK Breast Inter-
group. No response was obtained from The British
Psychological Society and the Association of Coloproc-
tology of Great Britain and Ireland. We were unable to
calculate an absolute response rate as the respective pro-
fessional bodies acted as intermediaries in the process in
order to protect the privacy of their members and han-
dled dissemination of the survey link. The median num-
ber of patients attending the HCP’s service that were
classed as living with and beyond cancer was 300 (range
0 – 5000). Breast and colo-rectal specialists, from dedi-
cated cancer centres with between 11 and 25 years of
practice experience made up the majority of the survey
responders. Full characteristics of the survey responders
are reported in Table 1.
Service provision
Seventy one percent of respondents reported that their
unit provided some form of specific assessment, inter-
ventions, or therapy for people who have completed
active treatment. HCPs identified that clinical nurse spe-
cialists (92%), clinical oncologists (62%), medical oncolo-
gists (54%), counsellors (51%), physiotherapists (52%),
psychologists (45%), surgeons (40%), and occupational
therapists (35%) were involved in post-treatment follow-
up care.
The five most frequent aspects of post-treatment care
specifically addressed as part of follow-up were fatigue
(84%), fear of recurrence (83%), anxiety (82%) depres-
sion/low mood (78%) and menopausal problems (76%):
please see Table 2 for full details. These elements were
similar in some respects to the HCP’s top five views of
patient needs, these being fear of recurrence (95%),
fatigue (94%), changes in physical capabilities (89%),
anxiety (89%) and depression (88%). Please see Table 3
for full details. However, the specifics of the dedicated
interventions delivered were broadly incongruent to HCPs
views on what was important to address in practice. The
five most common interventions offered were reported as
diet advice (72%), a medical assessment (69%), exercise
Table 1 Respondent characteristics
Country of service England 83% [231]
Scotland 9% [26]
Wales 4% [12]
Northern Ireland 3% [9]
Profession Othera 33% [89]
Medical Oncologists 30% [82]
Clinical Nurse Specialists 20% [54]
Clinical Oncologists 7% [20]
Surgeon 6% [16]
Medical Oncology trainee 3% [9]
Psychologist 0% [1]
Cancer specialty◊ Breast 49% [129]
Colorectal 23% [61]
Lung 23% [59]
Other (please specify)b 23% [59]
Gynaecological 22% [58]
Urological 22% [58]
Upper gastro-intestinal 17% [45]
Head and neck 13% [33]
Sarcoma 13% [33]
Hepatobiliary system 11% [28]
Dermatology 9% [23]
Lymphoma 8% [22]
Central Nervous System 8% [22]
Multiple Myeloma 8% [20]
Leukaemia 5% [14]
Institution◊ Cancer centre 52% [115]
Teaching hospital 29% [64]
District hospital 24% [53]
General hospital 19% [43]
Other (please specify)c 4% [8]
Community facility 1% [2]
Primary care 1% [2]
Years practising in cancer care 26+ years 19% [49]
16–20 years 23% [59]
11–15 years 24% [64]
21–25 years 13% [35]
6–10 years 13% [33]
0–5 years 8% [22]
aOther answers included: radiographer (49%), nurse (12%), research nurses
(9%), radiotherapists (6%), centre managers (5%), lay person (3%), survivorship
leads (3%), advanced nurse practitioners (2%), dosimetrists (1%), occupational
therapists (1%), physiotherapists (1%), radiologists (1%), and research
coordinator (1%)
bOther answers included: melanoma, primary cancer, all tumour sites,
testicular, paediatric, and geriatric
cOther answers included: private hospitals, information and support services
◊Multiple options available to respond and will add up to over 100%
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advice (65%), a one off ‘end of care’ assessment (62%) and
counselling (61%). Interventions such as CBT (16%),
mindfulness (21%) and return to work support (20%) were
amongst the most infrequently offered (please see Table 4).
It was not clear how HCP priority areas of fear of recur-
rence, depression and anxiety were addressed in practice.
Interventions provided were most often delivered by HCP
on an individual basis (76%), a median of two sessions,
lasting 30 min to 1 h (53%). Specific details of the inter-
ventions offered including the format, number, duration,
frequency and delivery method are described in Table 5.
HCP personal opinion
Results from the thematic analysis of the free text ques-
tion ‘what more could be done to support those living
with and beyond cancer?’ identified two key themes -
current provision & support and improving existing
services. Demographics of those providing free text
responses can be seen in Table 6.
Current provision and focus of support
Respondents detailed current support available in their
service, which included, home visits, ‘cancer support char-
ities’ clinical nurse specialists trained in CBT, holistic needs
assessments, home visits, supported self-management,
which included counselling, exercise support and a sexual
counsellor with wellbeing events and peer support regu-
larly available. One respondent highlighted that their ser-
vice does not discharge patients, allowing a patient to
access psychological support 19 years after primary treat-
ment. However, not all care was consistent; respondents
often wrote about how the current care of those leaving
active treatment was akin to abandonment:
‘Newly diagnosed patients are fully embraced with a wide
range of support, but completing treatment can be like
falling off a cliff into nothing’ (Cancer Nurse specialist)
Further concerns were raised about inconsistent care
both within and between trusts. Respondents indicated
Table 3 HCP’s views of needs of those living with and beyond
cancer
Very important
or important
Moderately
important
Unimportant
or of little
importance
Fear of recurrence 95% [174] 4% [7] 1% [2]
Fatigue 94% [172] 5% [9] 1% [2]
Anxiety 89% [163] 10% [18] 1% [2]
Changes in physical
capacity
89% [163] 10% [19] 1% [1]
Depression/low mood 88% [161] 11% [20] 1% [2]
Long-term medical
complications of treatment
85% [156] 11% [20] 4% [7]
Body image problems 83% [152] 15% [27] 2% [4]
Fear of death 81% [149] 16% [30] 2% [4]
Financial problems 81% [148] 16% [30] 3% [5]
Menopausal symptoms
if applicable
79% [145] 17% [31] 4% [7]
Sexual difficulties 79% [144] 18% [32] 4% [7]
Changes in cognitive
capacity
77% [143] 21% [38] 3% [5]
Other emotional reactions
(eg. guilt, shame, anger)
75% [138] 19% [35] 6% [10]
Social problems 73% [134] 21% [39] 6% [10]
Weight changes 73% [133] 25% [45] 3% [5]
Vocational/occupational
problems
72% [131] 20% [37] 8% [15]
Osteoporosis 67% [122] 28% [51] 6% [10]
Low self esteem 66% [118] 28% [52] 6% [10]
Spiritual needs 58% [106] 28% [51] 14% [26]
Note: figures in square parentheses are absolute numbers of responders
Table 2 Elements of post-cancer treatment addressed in aftercare
Aspects of living beyond cancer addressed
% of HCP
responding
Frequently/
Always
% of HCP
responding
Occasionally
% of HCP
responding
Rarely/Never
Fatigue 84% [115] 10% [13] 7% [9]
Fear of recurrence 83% [113] 13% [18] 4% [6]
Anxiety 82% [112] 15% [21] 3% [4]
Depression/low mood 78% [107] 19% [26] 3% [4]
Menopausal symptoms
if applicable
76% [102] 12% [16] 12% [16]
Financial problems 72% [99] 24% [33] 4% [5]
Body image problems 72% [98] 21% [29] 7% [10]
Long-term medical
complications of treatment
72% [98] 20% [27] 8% [11]
Changes in physical capacity 68% [93] 24% [33] 7% [10]
Osteoporosis 66% [89] 20% [27] 15% [20]
Other emotional reactions
(e.g. guilt, shame, anger)
65% [87] 28% [37] 7% [10]
Fear of death 63% [86] 28% [38] 9% [12]
Weight changes 56% [77] 34% [46] 10% [14]
Social problems 55% [75] 34% [47] 11% [15]
Low self esteem 53% [72] 31% [42] 16% [21]
Sexual difficulties 48% [66] 34% [47] 18% [24]
Changes in cognitive capacity 45% [62] 34% [47] 21% [28]
Vocational/occupational
problems
37% [51] 42% [57] 21% [29]
Spiritual needs 36% [48] 35% [47] 30% [40]
Note: figures in square parentheses are absolute numbers of responders
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that support available to patients across the UK should
be part of a standardised care pathway to combat the
inequalities in current provision:
‘Currently it is ad hoc and what patients may or may
not be offered very much depends on where patients
are treated. This wouldn’t be acceptable for treatment
such as chemotherapy and shouldn’t be acceptable for
after care treatment either.’ (Medical Oncologist)
‘I believe there are inequalities in what patients are
given, even across differing heath care teams within
the same cancer centre.’ (Therapeutic radiographer).
Respondents indicated interventions should be tailored
to an individual’s unmet needs and include educational,
return to work, psychological (such as mindfulness
training and CBT), exercise and dietary components.
Respondents often stated that the focus should be on
the recognition of cancer as a long term condition and
helping patients resume normality.
‘There is a need to rehabilitate patients post treatment
to get them back to their pre-morbid level of health
and hence increase chance of leading a normal life re
return to work and the benefits that brings - financially,
mentally etc.’ (Medical Oncologist)
Family and peer support was also highlighted as an
important element of the post-treatment follow-up
pathway.
Respondents referred to a need for HCPs to acknowledge
and address the long term effects of cancer that continue
far beyond active treatment:
‘Treating cancer is a long-term process and we have a
long way to go in terms of education and raising
awareness for all members of the cancer MDT, pri-
mary care, policy makers, providers, commissioners of
care, the media and the public about the fact that our
role as members of the cancer MDT should not
finish with the end of treatment or after the 5 years
of follow-up.’ (Medical Oncologist)
Respondents described the need for more commu-
nity based programmes and better linking and part-
nership between community teams, secondary,
primary and social care as well as voluntary sectors.
Further suggestions included ensuring ‘open access’
to multidisciplinary teams of ‘dieticians, psycholo-
gists, nurse specialists and Macmillan for financial
advice.’
Improving current support services
Respondents raised frequent concerns regarding the
underfunding of services, and the need for more time,
staff and funding to effectively support patients living
with and beyond cancer:
‘Ongoing funding for the services is a major issue, and
training of appropriate lay therapist’ (Clinical
Oncologist)
Suggested support strategies often included self-
management options with end of treatment summaries
with a:
‘variety of different formats to suit more people. (ie:
online, one off, peer etc…)’ (Radiographer Specialist)
A minority of respondents stated that focusing on
patients who have had cancer may take away resources
from other patient groups with equal needs:
Table 4 HCPs reports of Interventions offered in aftercare
Frequently/Always Occasionally Rarely/Never Don’t know
Interventions offered
Dietary advice or support 72% [105] 19% [28] 5% [7] 4% [6]
Medical assessment 69% [100] 21% [30] 10% [14] 1% [2]
Exercise therapy or advice 65% [95] 18% [26] 11% [16] 6% [9]
One off assessment at the end of treatment 62% [91] 12% [18] 17% [24] 9% [13]
Counselling 61% [89] 30% [44] 6% [9] 3% [4]
Peer Support 57% [83] 25% [36] 8% [12] 10% [15]
Family counselling/therapy 23% [34] 37% [54] 28% [41] 12% [17]
Mindfulness training 21% [30] 20% [29] 31% [45] 29% [42]
Vocational rehabilitation/return to work programme 20% [29] 19% 32% [47] 30% [43]
Cognitive behavioural therapy 16% [24] 40% [59] 25% [36] 19% [27]
Acceptance and commitment therapy 9% [10] 10% [14] 34% [49] 50% [73]
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‘In the current economic climate, there is a danger
that the powerful cancer lobby will take resources
away from patients with mental health issues and
neurological illness which are far more debilitating in
the long term than being a cancer survivor.’ (Medical
Oncologist)
Discussion
The results of this national survey of post-cancer treat-
ment follow-up care, represent the most up-to-date and
comprehensive data-set that the authors are aware of
that assesses current provision. Our key findings were
Table 5 Delivery of the interventions delivered in after care
Format of sessions ◊
Individual support facilitated
by health care professionals
76% [100]
Group support facilitated
by healthcare professional
74% [97]
Group peer support 65% [85]
Individual peer support 17% [22]
None of the above
(please specify)a
5% [7]
Number of sessions
of aftercare offered
1 28% [36]
2 18% [23]
3 17% [22]
4 10% [13]
5 13% [17]
More than 5 (please
specify number)b
15% [20]
Duration of session Less than 30mins 21% [27]
30 min – 1 h 53% [69]
1 – 2 h 18% [24]
2 h + 9% [11]
Frequency of sessions Once 6% [8]
Weekly 22% [28]
Fortnightly 6% [7]
Monthly 10% [13]
Intermittently 33% [42]
Not applicable 12% [15]
Less often (please specify) 11% [14]
Delivery of sessions ◊ Face-to-face 95% [121]
Telephone 37% [47]
Other (please specify) 8% [10]
Web based 2% [2]
Skype/Facetime 0.0% [0]
Note: figures in square parentheses are absolute numbers of responders
aOther answers included: in response to need, none known, signposting to 3rd
sector services
bOther answers ranged from 0 to 99, median = 7.5
◊multiple options were available for response and will add to above 100%
Table 6 Demographics of free text respondents
Country of service
100% [278]
England 81% [110]
Scotland 9% [12]
Northern Ireland 4% [5]
Wales 2% [3]
Profession 97% [271] Medical Oncologists 35% [48]
Othera 29% [40]
Clinical Nurse Specialists 18% [24]
Clinical Oncologists 9% [12]
Surgeon 6% [8]
Medical Oncology
trainee
3% [4]
Psychologist 0% [0]
Cancer specialty◊
94% [262]
Breast 48% [65]
Other (please specify)b 25% [34]
Urological 24% [32]
Lung 22% [30]
Gynaecological 21% [29]
Colorectal 21% [28]
Upper Gastro-intestinal 15% [20]
Sarcoma 12% [16]
Hepatobiliary Nervous
System
10% [13]
Head and Neck 9% [12]
Dermatology 7% [10]
Lymphoma 7% [9]
Multiple Myeloma 6% [8]
Central Nervous
System
5% [7]
Leukaemia 3% [4]
Institution◊ 80% [222] Cancer Centre 52% [70]
District Hospital 24% [33]
Teaching Hospital 24% [33]
General Hospital 21% [29]
Other (please specify)c 4% [5]
Primary Care 2% [2]
Community Facility 2% [2]
Years practicing in
cancer care 94% [262]
26+ years 19% [26]
11–15 years 26% [35]
16–20 years 27% [36]
6–10 years 14% [19]
21–25 years 12% [16]
0–5 years 3% [4]
aOther answers included: radiographer, research nurse, radiotherapists,
survivorship lead (project manager), occupational therapist
bOther answers included: across all cancers, adolescents and young adults, all
radiotherapy, testicular
cOther answers included: private hospitals, information and support services
◊Multiple options available to respond and will add up to over 100%
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that fear of recurrence, fatigue, changes in physical
capabilities, anxiety and depression were highlighted by
HCPs as the most important areas to address in post-
treatment aftercare. There was no universal or consist-
ent provision of any specific assessments, intervention
or therapy, and the interventions offered did not clearly
match views on what is most important. It is not clear
how HCP priority areas of fear of recurrence, depression
and anxiety are currently addressed. Psychological inter-
ventions such as CBT, which are supported by the evi-
dence base, are amongst the least frequently offered
services. Key themes from our free text analysis have in-
dicated that provision not only varies across the country
but can be inconsistent even within trusts. Rather worry-
ingly there appears to be a gap between identified pa-
tient need and provision of care even within a cancer
centre. Providing routine follow-up for patients treated
with curative intent is being increasingly discouraged in
the NHS in favour of patient directed self-management
and therefore the ability to identify and manage patients’
needs is even more imperative. Our findings demon-
strate the current variable state of provision for these pa-
tients. Knowing both which HCPs will take
responsibility, how to access appropriate services and
what shape those services will take is not clear. It is im-
portant to note recent data have reported that nursing
and allied health care professionals involved in cancer
care have expressed a need for more training around the
knowledge of long-term health effects of cancer and its
treatments and psychosocial care [19].
Previous prospective observational studies have re-
ported that unmet needs at the end of cancer treatment
in the NHS tend to stay unmet [4]. Since the publication
of these data in 2009, it is unclear how current aftercare
in the NHS has adapted to change or has improved. This
is despite two key government policy documents in 2011
and 2015 highlighting the increasing importance of can-
cer survivorship [20, 21]. Cancer Research UK’s own re-
port around implementation of the UK’s cancer
strategies has pointed out that, whilst the importance of
living with and beyond cancer services in the UK is bet-
ter appreciated (likely due to growing prevalence), the
'soft’ aspect of these services can lead to them being
viewed as lower priority and particularly vulnerable in
‘challenging financial climates’ [22]. Currently, such ser-
vices are often not commissioned by the NHS and are
left to specialist cancer charities to fund. It would appear
then that a full economic evaluation of evidence-based in-
terventions specifically for the health service would be an
important contribution to this narrative.
The content and format of the interventions that are
already currently offered, raise several issues. Firstly, des-
pite an evidence base for efficacy (particularly in breast
cancer) [11], approaches such as CBT were seldom
available for patients. Only around a third of our sample
addressed vocational or occupational rehabilitation in
post-treatment aftercare. This is despite over 70% of the
HCPs involved in the survey rating needs in regards to
vocational/occupational problems as either important or
very important. A recent systematic review of qualitative
data reported that in post-treatment cancer survivors
returning to vocations and paid work, this not only pro-
vides financial security but also work is an important
element of self-identity, self-esteem and healthy social
relationships [17]. It could be that only around a third of
patients going through these services had occupations or
vocations prior to cancer treatment, but that could be
seen as a very conservative estimate.
Delivery of the interventions that were offered usually
consisted of a one-off, face-to-face session lasting around
30–60 min. While this is much longer than a typical fol-
low up appointment and is aimed at identifying prob-
lems and signposting patients on to further services, the
effectiveness of the intervention in this format is uncer-
tain. Such a limited investment in time may be under-
standable given the increasing prevalence of cancer
survivors and that aftercare already struggles to fit with
system capacity [22]. Even if time is limited, it is import-
ant to both match the intervention to the problem and
provide an approach that has an evidence base. However,
it is a matter of some uncertainty as to whether such
limited contact time could reliably reproduce clinically
meaningful effect sizes of interventions reported in peer-
reviewed literature. For instance, this is highly unlikely
to be the case in terms of fostering meaningful exercise
behaviour changes and sustaining this behaviour in
sedentary cancer survivors [23].
It is important to acknowledge some key limitations of
this survey and analysis. The recruitment procedure did
not allow us to calculate response rates for this study as
professional bodies acted as intermediaries in the con-
tact process. However, 70% of NHS acute trusts provided
data. We are not aware of any other recent studies
addressing these questions and as such this provides a
useful and relevant available dataset on the topic. In
addition, we relied on respondents to be a member of
professional bodies or groups and to be actively reading
emails from the group, which might have biased the
sampling. Finally, we did not survey cancer related char-
ities and voluntary agencies that also provide aftercare for
cancer survivors. For example, Macmillan offer ‘The
Recovery Package’ to support people living with and be-
yond cancer, which involves a Holistic Needs Assessment,
treatment summary, cancer care review, and health and
wellbeing clinics. The intervention is part of an overall
self-management support package incorporating physical
activity, managing the consequences of treatment, infor-
mation and financial and work support [24]. Our total
Duncan et al. BMC Cancer  (2017) 17:186 Page 7 of 9
number of survey responders is a small proportion of the
total number of NHS staff involved in cancer care.
Conclusions
The results of our survey indicate that there does not
seem to be a universal, standardised, evidence based
approach to post-cancer treatment needs assessment, or
interventions to either improve QoL or address unmet
needs of patients. Whilst dietary and exercise advice are
more frequently offered, it seems that the priority areas
identified by HCP of fear of recurrence, depression and
anxiety are not adequately addressed in standard prac-
tice. HCPs’ personal views highlighted that provision is
often variable, not only between care centres, but even
within specialities. Given the uncertain economic
climate of the NHS, a full economic evaluation of an evi-
dence based pathway would be an essential contribution
to the narrative of providing cost-effective post-cancer
treatment aftercare.
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